The PE Playbook: What To Expect In 2022 (Paul Keckley)
Private equity’s impact on healthcare delivery accelerated during the pandemic. It’s likely to continue with profound implications for traditional providers in 2022.
4 guidelines published by AGA in 2021 (AGA)
Recommendations include testing protocol for cirrhosis patients, early use of biologics for patients with Crohn’s disease, IGB weight loss strategy, and COVID testing protocol.
Top 31 Microbiome startups (Medical Startups)
Microbiome startups develop new microbes, microbe-based treatments, and microbiome diagnostic technologies. The article enlists the top microbiome startups across the world.
Managing cancer risk in IBD patients (The Medical Independent)
Patients with inflammatory bowel disease are at increased risk of cancer, and the use of immunosuppressive therapies thus needs to be carefully and individually assessed in light of their risk profile.
COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.